Brief: TScan Therapeutics Establishes Facility To Manufacture T Cell Receptor Engineered T Cell Therapies
02/12/2021 12:59
Dec 2 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS ESTABLISHES FACILITY TO MANUFACTURE T
CELL
RECEPTOR ENGINEERED T CELL THERAPIES
Source text for Eikon: ID:nGNX38ndLW
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing